This page does not exist
Explore our environment
-
Market trend: Highly specialized hyaluronic acid by CDMOs
Aesthetic Medicine Trends 2025–2026: Toward Personalization, Safety, and Advanced Delivery Systems The aesthetic and broader…
-
ANVISA certifies SyrhaTech’s medical device manufacturing system
A New Milestone for SyrhaTech The SyrhaTech teams are proud to announce that we have…
-
10 Key Figures to Understand SYRHATECH, the Swiss CDMO Shaping the Future of Healthcare
Located in Switzerland, at the intersection of precision and innovation, SYRHATECH is a medical device…
-
Oral Tissue Regeneration: An Innovative R&D Project at Syrhatech
At Syrhatech, we support our clients in the research and development of advanced technology. We…
-
Syrhatech completes a financinground of CHF 4.5 million
Plan-les-Ouates, Geneva, April 2025 – Syrhatech, a French-Swiss CDMO innovating in thedevelopment and manufacture of…
-
Welcoming the New Year with Innovation and Leadership at SyrhaTech
As we step into the New Year, SyrhaTech is excited to announce a significant addition…
-
Financing the future: SyrhaTech aims for new heights
No company is more future-oriented at the moment than SyrhaTech: a Biotech medical device company…
-
SyrhaTech supports organization of ISHAS’s awards
For the past four months, SyrhaTech has been in partnership with the learned society ISHAS…
-
SyrhaTech, an aesthetic medical device company, between France and Switzerland
The SyrhaTech team is made up of people from Europe’s four corners. Everyone is very…
-
SyrhaTech joins CDMO France
SyrhaTech is proud to announce that we have joined the “CDMO France” association. CDMO France…
